The 2026 Retirement Accelerator: 3 Trades With 1,000% Gain Potential

Let me be direct with you…

The three trades in this report are not for the faint of heart.

They are not the kind of positions you build your entire retirement around. They are not “safe.“ They are not conventional.

I want you to understand that clearly before you read a single word further.

What these trades ARE is this…

A calculated, limited-risk way to place a high-conviction bet on one of the most powerful technological revolutions in modern history – I’m talking about the $56 trillion quantum computing wave that I believe Nvidia is about to ignite.

The instrument we’re using is deep out-of-the-money call options.

When you buy a call option, you are paying a small premium for the RIGHT – not the obligation – to purchase shares at a specific price by a specific date. If the stock doesn’t reach that price, you lose the premium you paid. If it does – and does so dramatically – the returns can be extraordinary.

These trades are designed to put a small amount of capital at risk in exchange for an outsized potential reward. Think of it as buying a lottery ticket – but one with far better odds and a rational investment thesis behind it.

My rule of thumb: Never allocate more than you are genuinely prepared to lose entirely. I suggest sizing these positions at no more than 1% to 2% of your total portfolio – each. Combined, these three trades should represent a small but meaningful lottery ticket on what I believe will be the defining technology story of the decade.

If you’re newer to options, scroll down and read the “Quick Options Primer” section of this report before moving on.

Otherwise,  let’s dive in…

Why Options? Why Now?

When a major catalyst is approaching – a product announcement, a partnership reveal, a conference keynote – options are one of the most powerful tools available to the individual investor.

Here’s the math that makes options so compelling: If you buy 100 shares of a $50 stock, you’re spending $5,000. If that stock goes to $75, you’ve made $2,500 – a 50% return.

But if instead you spent $500 on call options giving you the right to buy that stock at $55, and the stock runs to $75 before expiration? That same $500 could turn into $2,000 or more – a 300% to 400% gain on a smaller amount of capital at risk.

That asymmetry is what makes options so powerful around high-conviction catalysts. And I believe Nvidia’s quantum computing announcement – and its ripple effects across the sector – represents exactly that kind of catalyst moment.

I’ve identified three trades across three distinct companies. Each one is positioned in its own way to benefit from the quantum computing revolution.

Let me walk you through each of them…

Trade No. 1

Quantum Computing Inc.

Recommendation: Buy the Quantum Computing Inc. (Nasdaq: QUBT) July $8 call options at market.

Ticker: QUBT (Nasdaq)

Option: July $8 Call

Risk Profile: Highly speculative

The Pure-Play Quantum Bet

If you want direct, concentrated exposure to the quantum computing revolution, Quantum Computing Inc. is the name.

This is a small, pure-play quantum computing company – the kind of company Wall Street largely ignores right now. And that’s exactly why it interests me.

The market has a pattern: It sleeps on transformative technologies until a major catalyst forces it awake. We saw it with Nvidia in 2004. We saw it with IonQ when Nvidia announced a quantum partnership and the stock shot up more than 1,000%. And I believe we’re about to see it again.

Quantum Computing is developing photonic quantum computing technology, a next-generation approach that sidesteps some of the biggest limitations of traditional quantum hardware. Photonic systems can operate at room temperature, are more scalable than many competing architectures, and are well-suited for integration with existing fiber-optic telecommunications infrastructure.

Here’s what makes this trade compelling right now: The $8 strike puts us above current trading levels, but well within reach if Nvidia’s quantum announcement sends the sector into a frenzy. We have seen quantum computing stocks move 30%, 50%, even 100% in a single week following major catalysts. The July expiration gives us a meaningful runway to be right.

The Potential: If the sector catches fire – as I believe it will – a move to $8 or above is not out of the question. Options at these levels could return 500% to 1,000% or more on a sharp move. But again, if the stock doesn’t reach $8 before the July expiration, this option expires worthless.

Recommendation: Buy the Quantum Computing Inc. (Nasdaq: QUBT) July $8 call options at market.

Position sizing reminder: Keep this to a small, defined dollar amount you are comfortable losing entirely.

Trade No. 2

Moderna Inc.

Buy the Moderna (Nasdaq: MRNA) August $55 call options at market.

Ticker: MRNA (Nasdaq)

Option: August $55 Call

Risk Profile: Highly speculative

The Quantum Drug Discovery Leap

Earlier, I laid out the case for quantum computing’s impact on the pharmaceutical industry. The short version: Drug discovery today is brutally slow and expensive. It takes up to $2.5 billion and more than a decade to bring a single drug to market. Quantum computing promises to collapse that timeline dramatically – testing trillions of molecular combinations simultaneously, cutting years of lab work down to days.

No company is more exposed to that upside than Moderna.

Moderna built its entire platform on mRNA technology – a radically different approach to medicine that was considered fringe science before COVID-19 proved it worked at scale. The company has already demonstrated it can move fast when it has the right tools. Quantum computing is the next set of tools.

Moderna’s pipeline includes programs in oncology, rare diseases, cardiovascular conditions, and infectious diseases. Many of these programs hinge on precisely the kind of molecular modeling that quantum computing will accelerate. When quantum drug discovery goes from theoretical to operational – and I believe Nvidia’s announcements will move that timeline forward considerably – companies like Moderna will be among the biggest beneficiaries.

Moderna shares have been under pressure for the past two years as COVID-19 vaccine revenues declined. The stock has pulled back significantly from its highs. That creates an unusual setup: a world-class biotech platform, deeply discounted, with a potential quantum-powered re-rating on the horizon.

The $55 strike on August calls gives us exposure through the summer – long enough to capture any quantum-driven momentum in the biotech sector following Nvidia’s conference.

The potential: A move to $55 would require meaningful upside from current levels. If Moderna catches a quantum tailwind and broader biotech sentiment shifts, this options position could return multiples on the premium paid. As always, the entire premium is at risk.

Recommendation: Buy the Moderna (Nasdaq: MRNA) August $55 calls at market.

Position sizing reminder: Keep this to a small, defined dollar amount you are comfortable losing entirely.

Trade No. 3

International Business Machines

Buy the IBM (NYSE: IBM) August $250 calls at market.

Ticker: IBM (NYSE)

Option: August $250 Call

Risk Profile: Speculative (Lower risk vs. the previous two)

The Quantum Infrastructure Giant

Not every trade in this report needs to be a moonshot.

IBM is the most established name in quantum computing – full stop. The company has been building quantum hardware for longer than most Wall Street analysts have been following the space. Its IBM Quantum platform already has thousands of users across research institutions, corporations, and governments worldwide. And with its 1,000+ qubit processors and its open-source Qiskit platform, IBM is, arguably, the infrastructure layer of the quantum revolution.

Think of IBM the way you might have thought of Cisco in 1999. While flashier names captured the headlines, Cisco built the pipes that the internet ran through. IBM is building the pipes that quantum computing will run through.

What’s changed recently is momentum. IBM has been quietly executing on its quantum road map – hitting qubit milestones ahead of schedule, expanding partnerships, and integrating its quantum systems with hybrid classical-quantum workflows. When Nvidia begins to publicly champion quantum computing as the next frontier, IBM is one of the names institutional investors will immediately reach for.

The $250 strike on August calls is the most conservative of our three trades. IBM is already in the $200 range, meaning the gap to our strike is smaller than the gap in the other two trades. That means this option is less of a long shot – but correspondingly, the premium will be higher and the percentage upside, while still substantial, will be more measured.

Think of this trade as the “anchor” of the three – the most likely to move in the right direction, but also the one requiring the most capital if you want meaningful exposure.

The potential: A move to $250 is achievable with a strong quantum computing narrative and positive earnings. Options at this level could return 300% to 700% if the stock makes a meaningful move to and through the strike price before August expiration.

Recommendation: Buy the IBM (NYSE: IBM) August $250 calls at market.

Position sizing reminder: Keep this to a small, defined dollar amount you are comfortable losing entirely.

How to Build Your Quantum Options Portfolio

The beauty of options is that you can build a meaningful position in all three of these trades for a fraction of what you’d spend buying the stocks outright. Here is a simple framework for sizing these trades intelligently.

Sample Allocation for a $50,000 Portfolio

Quantum Computing July $8 Calls | $250 – $500 | (0.5% – 1.0% of portfolio)

Moderna August $55 Calls | $250 – $500 | (0.5% – 1% of portfolio)

IBM August $250 Calls | $500 – $1,000 | (1% – 2% of portfolio)

Total capital at risk: $1,000 – $2,000 (2% – 4% of portfolio)

The key principle: The total combined position in all three trades should never exceed 5% of your investable portfolio.

If your portfolio is larger or smaller, scale proportionally. The percentages matter more than the absolute dollar amounts.

Also worth noting: You do not have to make all three trades. You can start with one. You can paper trade (simulate) the others and observe. The goal here is to give you structured, limited-risk exposure to a high-conviction theme – not to pressure you into any single position.

A Quick Options Primer: What You Need to Know

If you have never traded options before, here is everything you need to understand to execute these trades.

What a Call Option Is

A call option gives you the right – but not the obligation – to buy 100 shares of a stock at a specific price (called the “strike price”) before a specific date (called the “expiration date”). You pay a premium upfront for this right. If the stock never reaches the strike price before expiration, you lose the premium. If it does – and surpasses it – your option gains value rapidly.

Understanding “Deep Out of the Money”

When the current stock price is well below the strike price, the option is called “deep out of the money.” These options cost less – because they require a bigger move to become profitable – but offer the highest percentage returns if that move occurs. All three trades in this report are, to varying degrees, out of the money.

How to Place the Trade

Most online brokerages – Schwab, E-Trade, Fidelity, Interactive Brokers, etc. – allow options trading. You will need to apply for options trading approval (typically Level 1 or Level 2) if you haven’t already. Once approved…

• Go to the options chain for the stock (e.g., QUBT).
• Select the correct expiration month (July for QUBT, August for MRNA and IBM).
• Select the correct strike price ($8, $55, or $250).
• Choose “Buy to Open.”
• Choose “Call.”
• Select the number of contracts (1 contract = 100 shares of exposure).

You can use a limit order near the ask price to get a fair fill. I recommend placing these trades “at market” or with a limit just above the current ask to ensure execution.

When to Exit

There are two scenarios in which I would exit these positions:

1. If the trade doubles: Consider selling half your position when it doubles. This takes your original capital off the table and lets the rest ride for free.
2. If expiration approaches with no movement: Options lose value as they approach expiration (a concept called “time decay”). If a position is deeply underwater with fewer than three weeks to expiration, it is often better to close it for whatever value remains rather than hold to zero.

Why I Believe This Is the Right Moment

I want to close this report the way I opened it – with complete candor.

These are risky trades. I would never pretend otherwise. But risk is not the same as recklessness. There is a difference between gambling blindly and making a calculated, thesis-driven bet with money you can afford to lose.

The thesis is simple: Nvidia is about to announce its most significant breakthrough since the GPU. The fusion of artificial intelligence and quantum computing – what I have been calling “Q Day” – has the potential to ignite a sector-wide revaluation of quantum computing stocks. We have seen this happen before with IonQ (up more than 1,000% after its Nvidia partnership), with Quanta Services (a 10X run), and with Super Micro Computer (a 25X move in three years).

The three trades in this report are designed to give you exposure to three different flavors of the same thesis: a pure-play quantum company (QUBT), a pharmaceutical company poised to be transformed by quantum drug discovery (MRNA), and the established quantum infrastructure leader (IBM).

Together, they form a quantum options portfolio that can be built for as little as $1,000 – with 1,000% upside potential if the thesis plays out.

Summary of Recommended Trades

Trade No. 1:  Buy the Quantum Computing Inc. (Nasdaq: QUBT) July $8 calls at market.

Trade No. 2:  Buy the Moderna (Nasdaq: MRNA) August $55 calls at market.

Trade No. 3:  Buy the IBM (NYSE: IBM) August $250 calls at market.

Suggested combined allocation: 2% to 5% of total investable portfolio.

Risk: Total loss of all premium paid is possible.